Your country

Tools that support it use your country for local currency, number formats, units and paper size. Your choice is saved only in this browser.

Type a name or a two-letter code. Use the up and down arrow keys to move through the countries, Enter to choose one and Escape to close.

10-Year Heart Disease Risk Calculator (PREVENT)

Your 10- and 30-year cardiovascular risk from the AHA PREVENT equations, with the PCE.

Health No upload Works offline Free, no sign-up

About you

Sex
years
30–79. Not for people who already have heart disease or have had a stroke.
Cholesterol
mg/dL
mg/dL
Blood pressure and health
mmHg
The upper number, for example 130 in 130/85.
Kidney function
mL/min/1.73 m²
From a kidney function test; 15–140.
Height and weight (for heart-failure risk)
cm
kg
BMI —
For the older Pooled Cohort Equations only

PREVENT does not use race; the PCE have separate equations for Black and White adults.

10-year risk of cardiovascular disease —

Heart attack, stroke or heart failure, by the AHA PREVENT equations.

10-year ASCVD risk: —

PREVENT results

Outcome10 years30 years

Each outcome has its own equation, so total cardiovascular disease is less than ASCVD plus heart failure.

Pooled Cohort Equations (for comparison)

—

10-year risk of a first heart attack or stroke (ASCVD), the estimate the earlier ACC/AHA guideline used.

Next steps

For general information only, not medical advice. Consult a qualified health professional for advice about your situation.

About the 10-Year Heart Disease Risk Calculator (PREVENT)

The PREVENT equations from the American Heart Association estimate the chance that an adult aged 30 to 79 without heart disease will have a cardiovascular event — a heart attack, stroke or heart failure — in the next 10 years and, up to age 59, the next 30 years. US cholesterol and blood-pressure guidelines now use them to decide who is offered a statin or blood-pressure medicine.

This calculator runs the PREVENT base model on your age, sex, cholesterol, blood pressure, diabetes, smoking, kidney function (eGFR), BMI and medicines, shows the category each result falls in, and adds the older Pooled Cohort Equations (PCE) 10-year ASCVD risk for comparison. Everything is calculated in your browser.

How to use it

  1. Enter your sex, age (30–79), total and HDL cholesterol (mg/dL or mmol/L, as on your lab report) and your systolic (upper) blood pressure.
  2. Tick what applies: blood-pressure medicine, diabetes, current smoking, statin.
  3. Enter your eGFR from a kidney blood test — or switch to creatinine and the tool works out eGFR with the CKD-EPI 2021 equation PREVENT was built with.
  4. Add height and weight for the heart-failure risk (PREVENT uses BMI only there). Choose the PCE race group for the comparison.
  5. Read your risks, their categories and the notes; Copy result to take them to your doctor.

Examples

Woman, 50, total 240 / HDL 55 mg/dL, treated systolic 160, BMI 35, eGFR 90 (the PREVENT paper’s example)
Result
10-year: cardiovascular disease 5.4% · ASCVD 3.6% (borderline) · heart failure 2.5% — 30-year: 30.7% · 19.9% · 18.5%
The same woman as a current smoker
Result
10-year: cardiovascular disease 9.3% · ASCVD 6.0% (intermediate) · heart failure 4.7%
Man, 55, total 213 / HDL 50 mg/dL, untreated systolic 120, non-smoker, no diabetes (PCE example)
Result
Pooled Cohort Equations, White or other: 10-year ASCVD 5.4% (the guideline table, which rounds each step, shows 5.3%)

Common uses

  • Getting your 10-year risk before a check-up, so you can ask informed questions about statins or blood-pressure treatment.
  • Seeing how much quitting smoking or lowering blood pressure would change the estimate (change one input at a time).
  • Comparing the new PREVENT result with the PCE result your doctor may have used before.

How PREVENT works

PREVENT was developed and validated in more than 6 million US adults from research cohorts and health-care records. Compared with the PCE it adds kidney function (eGFR), statin use and, for heart failure, BMI; it predicts heart failure as well as atherosclerotic disease; it starts at age 30; and it does not use race. Three outcomes are estimated separately:

  • Total cardiovascular disease — heart attack, death from coronary heart disease, stroke or heart failure
  • ASCVD (atherosclerotic cardiovascular disease) — heart attack, death from coronary heart disease or stroke
  • Heart failure

Because each has its own equation, total CVD is less than ASCVD plus heart failure.

The formula

Each PREVENT model is a logistic equation, risk = eˣ ÷ (1 + eˣ), where x adds a coefficient times each predictor. The predictors are centred and scaled:

  • age: (age − 55) ÷ 10, plus age² in the 30-year models
  • non-HDL cholesterol in mmol/L − 3.5, and (HDL cholesterol − 1.3) ÷ 0.3
  • systolic BP in two parts: (lower of SBP and 110 − 110) ÷ 20 and (higher of SBP and 110 − 130) ÷ 20
  • eGFR in two parts: (lower of eGFR and 60 − 60) ÷ −15 and (higher of eGFR and 60 − 90) ÷ −15
  • BMI, heart failure only: (lower of BMI and 30 − 25) ÷ 5 and (higher of BMI and 30 − 30) ÷ 5
  • diabetes, current smoking, blood-pressure medicine and statin as 1 or 0, with interaction terms for treated blood pressure, treated cholesterol and age

The coefficients are the published base-model values (Supplemental Table S12 of the PREVENT paper); they reproduce the paper’s worked examples exactly.

The Pooled Cohort Equations use natural logs of age, total and HDL cholesterol and systolic BP in four sex and race groups: risk = 1 − S₀^exp(Σβx − mean), with the coefficients, means and baseline survival of Table A of the ACC/AHA risk-assessment guideline.

What the categories mean

  • PREVENT 10-year ASCVD risk — the ACC/AHA multisociety dyslipidemia guideline groups it as low (below 3%), borderline (3% to below 5%), intermediate (5% to below 10%) and high (10% or more) when deciding about cholesterol-lowering treatment, together with LDL cholesterol, other risk-enhancing factors and, sometimes, a coronary calcium scan.
  • PREVENT 10-year total CVD risk — the AHA/ACC high blood pressure guideline advises medicine for stage 1 hypertension (130–139/80–89 mmHg) when this risk is 7.5% or more, or with diabetes or chronic kidney disease.
  • PCE 10-year ASCVD risk — the earlier cholesterol guideline, now replaced, used low (below 5%), borderline (5% to below 7.5%), intermediate (7.5% to below 20%) and high (20% or more).

PREVENT usually gives lower ASCVD estimates than the PCE for the same person, which is why its cut-offs are lower. A category is a starting point for a conversation with your doctor, not a decision.

People of South Asian descent

Neither model was developed specifically for people of South Asian descent. In a Kaiser Permanente study of South Asian adults, the PCE underestimated risk in the low-risk group, and US guidance has counted South Asian ancestry as a risk-enhancing factor. For PREVENT the evidence is still limited: in a large Californian health system it predicted risk reasonably well in Asian Indian patients, but in an Indian study of people admitted with a heart attack, most had not been classed as high risk beforehand by PREVENT or the other scores. If you are of South Asian descent, a "low" result may understate your risk — discuss it with your doctor.

Sources

Limitations

  • Only for adults aged 30–79 who have never had a heart attack, stroke, heart failure or other cardiovascular disease. If you have, these equations do not apply — your doctor will treat you as high risk.
  • The equations were developed in US populations and accept total cholesterol 130–320 mg/dL, HDL 20–100 mg/dL, systolic BP 90–200 mmHg and eGFR 15–140; heart-failure risk needs a BMI from 18.5 to below 40.
  • This is the PREVENT base model. The full model can also use urine albumin-to-creatinine ratio, HbA1c and a US ZIP-code deprivation index, which are not included here.
  • Some conditions — very high LDL cholesterol, diabetes, chronic kidney disease — can call for treatment whatever the calculated risk; your doctor takes them into account.

Privacy

Everything happens in your browser. What you enter or open here is not uploaded or stored by MySmartCoPilot.

Frequently asked questions

Why is my PREVENT risk lower than the PCE result?

PREVENT was built on larger and more recent data, and for the same person it usually gives a lower ASCVD estimate: in the PREVENT paper, people with a PCE risk of 7.5% had a median PREVENT ASCVD risk of 4.9% (women) and 3.7% (men). That is why the current cholesterol guideline uses lower PREVENT cut-offs (5% and 10%) than the old PCE ones (7.5% and 20%).

Which result matters most?

Doctors look at ASCVD risk for cholesterol treatment and total cardiovascular risk for blood-pressure treatment. Heart-failure risk matters for blood pressure, weight, diabetes and kidney care. Ask your doctor which applies to you.

Why is the 30-year risk shown only up to age 59?

The cholesterol guideline uses 30-year risk for adults aged 30 to 59, and from 60 a 30-year horizon runs to age 90 and beyond, where the estimate becomes questionable. For younger adults the 30-year risk shows the long-term effect of risk factors that a low 10-year risk can hide.

Where do I find my eGFR?

On a kidney function test or a routine metabolic panel. If the report shows only creatinine, switch the eGFR field to creatinine: the tool calculates eGFR with the CKD-EPI 2021 equation, the one PREVENT used.

Why does the PCE ask about race but PREVENT does not?

The PCE have separate equations for Black and for White adults; for people of other backgrounds the guideline says the White equations may be used. PREVENT’s authors treated race as a social construct and left it out, so its results do not depend on it.

Is my information sent anywhere?

No. All calculations run in your browser; nothing you enter leaves your device.

Quick answers and tool search

Type to search tools or to get a quick answer, for example 18% of 2500. Use the up and down arrow keys to move through the results, Enter to choose, and Escape to close.